Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
about
Rifabutin for treating pulmonary tuberculosisRifabutin for treating pulmonary tuberculosisWeekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsAnalysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosisEvaluation of rifapentine in long-term treatment regimens for tuberculosis in miceEvaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in miceEffectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelIntermittent azithromycin for treatment of Mycobacterium avium infection in beige miceEvaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection modelComparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophagesAnticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cellsHow effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosisTuberculosis and HIV: a partnership against the most vulnerable.Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Rifapentine: its role in the treatment of tuberculosis.Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected miceBactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.The use of anti-tuberculosis therapy for latent TB infectionAn update on the use of rifapentine for tuberculosis therapy.Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary TuberculosisNew regimens to prevent tuberculosis in adults with HIV infectionRole of pharmacogenomics in the treatment of tuberculosis: a reviewBactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in miceA physiologically based pharmacokinetic model of rifampin in mice.Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosisLeprosy therapy, past and present: can we hope to eliminate it?Current management options for latent tuberculosis: a review.The challenges of pharmacokinetic variability of first-line anti-TB drugs.Assessment of the Efficacy of New Anti-Tuberculosis Drugs.Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.
P2860
Q24242892-F6760E6B-589F-4BF5-898F-B668D9649A76Q24245293-0C91703D-E9D8-4A61-8FF2-CA67BFA58831Q24650581-EB3DE052-6C4A-40BD-B7F4-3B26B18D31C5Q28343546-AB5628E3-A2F9-42B0-9BAA-471835C0C9CAQ28343604-233F590F-DD09-47C5-94BD-254390467B37Q28344872-C1472BFB-1EAC-470C-A2E0-6F75EE2D5982Q28364123-21B5DD5F-9007-4725-A118-DE843AC22F84Q28368450-D182DE1A-BD10-45D5-8F04-B79BEC3BBD44Q28369131-3319AB2C-9CDE-4B1B-9A53-19B6D042679BQ28369170-9CD4B3CB-E941-4263-8726-062ACA05F995Q28378747-47DA5193-092C-4132-99E0-25F23B582994Q28379178-9CAC4533-D77B-47B6-9215-483BF6B3195AQ28379180-4075BAF9-31F0-48CD-BBA1-41A1765E7282Q28379615-E0FF580E-E7DC-4E85-B561-CFC0C43291AAQ30336184-E08CAAD2-E8E8-4081-87D8-086A4EB3EAC3Q31369223-7E9F6054-C116-4124-9BFE-390E7F0D22CFQ33735589-5FDC2096-D6FF-4C5C-B1CF-B4F0FEA0046BQ33779876-63F8A728-2909-4972-881C-D4B1A7C9B664Q33976250-6CA80138-AD0E-48C8-8267-54E8E0DBD2A0Q33980894-A82C105F-AB24-48F6-A71C-D470B09E3B79Q34077125-ED6F9337-527A-41A9-8772-5625A39FC91DQ34150929-AA74B03C-8AB3-499D-80A8-07DB0887B79EQ35026573-BF02009C-B143-4655-81A0-F27EA9EA4672Q35084363-124594B3-5FF7-4866-80AC-2CFF7F0F992CQ35112158-CCA628C6-F694-47CD-8ADB-F02A86A14283Q35122437-3D5F6FB3-5E0A-47EC-804F-2561E45B0E17Q35776635-8A646E5B-0262-4469-BB3F-8A7C579FE1E7Q36012300-DA753149-FB2D-4C6E-8A4B-05BA67959413Q36125227-98FC3146-9A28-4C24-B953-888C7B48F4A7Q36441540-FCAFDEFA-58BB-414C-9825-1B4CECC041C0Q36703065-6C858291-5DF6-4B55-ADF4-72319B444545Q36757635-20F0598F-21A3-49AA-85A2-FAF1FA024858Q37282694-30720226-298C-46C9-B06B-8BD3D8F21A3DQ37856731-58B8A033-C14C-4E78-B2C9-8B2E51C9AE19Q38066198-0B939DC2-AA72-4314-9923-97FDA15D4D43Q38977166-D434ED93-C70F-45B9-A9FA-6CF86914B1D4Q41572870-B249C250-A0E8-40E6-87F9-77EDBCD4DF12Q42861000-8174ABEA-C645-4C1A-BB8A-0C4DE75D1E85Q52559111-48305FC4-1161-4F6F-B886-8F657819659FQ54137044-CB006407-6493-4C45-A2A6-B22DECA8B171
P2860
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@en
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@nl
type
label
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@en
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@nl
prefLabel
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@en
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@nl
P2093
P2860
P356
P1476
Effectiveness of rifampin, rif ...... erapy of tuberculosis in mice.
@en
P2093
O'Brien RJ
Raviglione MC
Roscigno G
Truffot-Pernot C
P2860
P304
P356
10.1164/AJRCCM/148.6_PT_1.1541
P433
P577
1993-12-01T00:00:00Z